Pharmaceutical combination for the treatment of cancer
AssigneePiramal Enterprises Limited
InventorsOwe ORWAR, Sreesha SRINIVASA, Prabha MISHRA
Life of this patent
Estimating the term…
Abstract
The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor. The pharmaceutical combination of the present invention exhibits synergistic effect when used in the treatment of cancer.
Claims14
A method of treating cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a cyclin-dependent kinase (CDK) inhibitor and a therapeutically effective amount of at least one antioxidant enzyme inhibitor.
A pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor, for use in the treatment of cancer.
Dependencies are inferred from the claim text.